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Abstract
Background
In the mid-2000s, neonatal mortality accounted for almost 40% of deaths of children under 5
years worldwide, and constituted 65% of infant deaths in India. The neonatal mortality rate
in Andhra Pradesh was 44 per 1,000 live births, and was higher in the rural areas and tribal
regions, such as the Nagarkurnool division of Mahabubnagar district (which became Nagar-
kurnool district in Telangana in 2014). The aim of the CHAMPION trial was to investigate
whether a package of interventions comprising community health promotion and provision
of health services (including outreach and facility-based care) could lead to a reduction of
the order of 25% in neonatal mortality.
Methods and findings
The design was a trial in which villages (clusters) in Nagarkurnool with a population < 2,500
were randomised to the CHAMPION package of health interventions or to the control arm
(in which children aged 6–9 years were provided with educational interventions—the
STRIPES trial). A woman was eligible for the CHAMPION package if she was married and
<50 years old, neither she nor her husband had had a family planning operation, and she
resided in a trial village at the time of a baseline survey before randomisation or married into
the village after randomisation. The CHAMPION intervention package comprised commu-
nity health promotion (including health education via village health worker–led participatory
discussion groups) and provision of health services (including outreach, with mobile teams
providing antenatal check-ups, and facility-based care, with subsidised access to non-public
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health centres [NPHCs]). Villages were stratified by travel time to the nearest NPHC and
tribal status, and randomised (1:1) within strata. The primary outcome was neonatal mortal-
ity. Secondary outcomes included maternal mortality, causes of death, health knowledge,
health practices including health service usage, satisfaction with care, and costs. The base-
line survey (enumeration) was carried out between August and November 2007. After rando-
misation on 18 February 2008, participants, data collectors, and data analysts were not
masked to allocation. The intervention was initiated on 1 August 2008. After an inception
period, the assessment start date was 1 December 2008. The intervention ended on 31 May
2011, and data collection was completed on 30 November 2011. Primary analyses followed
the intention to treat principle. In all, 14,137 women were enrolled in 232 control villages, and
15,532 in 232 intervention villages. Of these, 4,885 control women had 5,474 eligible preg-
nancies and gave birth to 4,998 eligible children. The corresponding numbers in intervention
villages were 5,664 women, 6,351 pregnancies, and 5,798 children. Of the live-born babies,
343 (6.9%) in the control arm and 303 (5.2%) in the intervention arm died in their first 28
days of life (risk ratio 0.76, 95% CI 0.64 to 0.90, p = 0.0018; risk difference −1.59%, 95% CI
−2.63% to −0.54%), suggesting that there were 92 fewer deaths (95% CI 31 to 152) as a
result of the intervention. There were 9 (0.16%) maternal deaths in the control arm compared
to 13 (0.20%) in the intervention arm (risk ratio 1.24, 95% CI 0.53 to 2.90, p = 0.6176; 1 death
was reported as a serious adverse event). There was evidence of improved health knowl-
edge and health practices including health service usage in the intervention arm compared to
the control arm. Women in the intervention arm were more likely to rate their delivery and
postnatal care as good or very good. The total cost of the CHAMPION interventions was US
$1,084,955 ($11,769 per life saved, 95% CI $7,115 to $34,653). The main limitations of the
study included that it could not be masked post-randomisation and that fetal losses were not
divided into stillbirths and miscarriages because gestational age was not reliably reported.
Conclusions
The CHAMPION trial showed that a package of interventions addressing health knowledge
and health seeking behaviour, buttressing existing health services, and contracting out
important areas of maternal and child healthcare led to a reduction in neonatal mortality of
almost the hypothesized 25% in small villages in an Indian state with high mortality rates.
The intervention can be strongly justified in much of rural India, and is of potential use in
other similar settings. Ongoing changes in maternal and child health programmes make it
imperative that a similar intervention that establishes ties between the community and
health facilities is tested in different settings.
Trial registration
ISRCTN registry ISRCTN24104646
Author summary
Why was this study done?
• At the time this study was planned, the rate of death of children in the first 28 days of
life was very high in parts of rural India.
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• Earlier research had suggested that community health promotion, along with buttress-
ing existing maternity and neonatal services, might reduce this rate.
What did the researchers do and find?
• We randomised small villages in the Nagarkurnool district in Telangana either to the
package of health interventions or to control.
• We provided married women in the intervention villages with community health pro-
motion (including health education via village health worker–led participatory discus-
sion groups), outreach (including mobile teams providing antenatal check-ups), and
facility-based care (including subsidised access to non-public health centres).
• We enrolled 14,137 women in 232 control villages and 15,532 in 232 intervention vil-
lages. In all, 4,885 control women had 5,474 eligible pregnancies and gave birth to 4,998
eligible children. The corresponding numbers in intervention villages were 5,664
women, 6,351 pregnancies, and 5,798 children.
• We found that, of the live-born babies, 343 (6.9%) in the control arm and 303 (5.2%) in
the intervention arm died in their first 28 days of life, suggesting that there were 92
fewer deaths as a result of the intervention.
• We also found evidence of improved health knowledge and health practices including
health service usage in the intervention arm compared to the control arm.
What do these findings mean?
• The research findings mean that interventions such as those in the CHAMPION trial
can be strongly justified in much of rural India.
• Further research is needed to assess whether the interventions are of use in other rural
settings with similar socioeconomic and cultural patterns, similar neonatal mortality
rates, and the existence of some private health provision.
Introduction
Worldwide, nearly 40% of deaths in children under 5 years occur in the neonatal period (first
28 days of life) [1–3]: over 2.8 million neonates died in 2010 [4]. A review of global progress on
the Millennium Development Goals found that for goal 4 (reducing child mortality), mortality
in children under 5 years fell by 28% between 1990 and 2008, but reductions in neonatal mor-
tality remained slow [5,6].
In India, 1.68 million children aged under 5 years died in 2010, with 52% of the deaths
occurring in the first 28 days [1]—a neonatal mortality rate (NMR) of 39/1,000 live births [7].
Worldwide, India contributed nearly 25% of neonatal deaths [6], and NMRs in many regions
of India remained near the highest rates worldwide [8]. Three-quarters of neonatal deaths in
India were attributed to prematurity, low birthweight, neonatal infections, birth asphyxia, and
CHAMPION cluster randomised trial, Telangana, India
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birth trauma [9]. These deaths often occurred in rural environments, where children are com-
monly born at home and, while healthcare facilities were available, their quality could be inad-
equate [10]; in addition, poor health knowledge and practices including health service usage
may be contributory factors [6].
Studies [8] have shown the potential for reducing neonatal deaths through providing
home-based neonatal care, including management of sepsis [11]; behaviour change interven-
tions with a focus on hypothermia [12]; community mobilisation through participatory dis-
cussion groups (PDGs) [13]; and implementation of the Indian Integrated Management of
Neonatal and Childhood Illness programme for neonates born at home, which provides
improved treatment of illness for children and home visits for newborn care [14]. An addi-
tional strategy in the developing world has been to use health providers not affiliated with
the government to deliver services, particularly in areas where government service delivery
may be underperforming [10]. Evidence about the effectiveness of such strategies is scarce
[15–17].
The Lancet Neonatal Survival Series recommended future studies implement and evaluate
packages of care that provide family, community, outreach, and facility-based care [18]. A
subsequent systematic review [19] concluded that ‘the empirical evidence for the impact of
neonatal health care packages is a weak base on which to build effective programmes. . .. An
evidence-based approach to packaging interventions is clearly needed but requires substantial
investment in high-quality research’.
The CHAMPION cluster randomised controlled trial (RCT) was initiated in 2007 to evalu-
ate such a package of interventions, comprising community health promotion (including
health education delivered via village health worker [VHW]–led PDGs) and provision of
health services including outreach (mobile teams providing antenatal check-ups) and facility-
based care (specifically subsidised access to pregnancy-related care provided by non-public
health centres [NPHCs]). The primary hypothesis was that this package could reduce neonatal
mortality by 25%. A cluster RCT design was needed as the interventions were delivered at the
village level. An important element was an integral economic evaluation.
Around the time the trial was being designed and implemented, the Indian government
introduced a number of maternal and child health programmes, including incentives to
encourage institutional deliveries and care. One of the key elements of these programmes is
the involvement of the Accredited Social Health Activists (ASHAs), who were trained to refer
expectant women to medical institutions for delivery, and who also received incentives accord-
ingly. These initiatives were not, however, fully established in most of the CHAMPION villages
until well after the end of the trial (see Methods and Discussion).
The CHAMPION trial was implemented in Nagarkurnool district, Telangana. This was
then Nagarkurnool division, Mahabubnagar district, in the state of Andhra Pradesh (AP). AP
had one of the highest NMRs in India at the time, with 35% of neonatal deaths among children
who were premature or of low birthweight [20]. An additional 14.1% of neonatal deaths
involved neonatal infections, and 21.7% involved birth asphyxia and/or birth trauma [5,21,22].
The estimated NMR in rural regions of AP was between 49.2 [7] and 33 per 1,000 live births
[23]. Mahabubnagar was among the 100 most disadvantaged districts in the country [24]; it
was 90% rural [25] and had low levels of female literacy [26]. Nagarkurnool had a high tribal
population [25,27] and a particularly high mortality rate [28]. Since June 2014, this division
has been part of Telangana.
The aim of the CHAMPION trial was to investigate whether a package of interventions
comprising community health promotion and provision of health services including outreach
and facility-based care could lead to a reduction of the order of 25% in neonatal mortality.
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 4 / 28
Methods
Research ethics approvals
Approvals were obtained from the institutional review board of the L V Prasad Eye Institute,
Hyderabad, India (number LEC07002; February 2007) and from the ethics committee of the
London School of Hygiene & Tropical Medicine (LSHTM) (number 5166; June 2007).
The methods have been detailed [29], and are summarised below.
Eligibility
Clusters. The CHAMPION trial was conducted in 464 villages (clusters) in Nagarkurnool
with a population below 2,500, as larger villages generally have better access to health services,
lower neonatal mortality rates, and therefore less potential to benefit from the interventions.
Women. A list of eligible women in each village was compiled from a baseline survey
(enumeration) conducted before randomisation. A woman was eligible at enumeration if she
was married and aged less than 50 years, neither she nor her husband had had a family plan-
ning operation, she was resident in the village at the time of the baseline survey, and she ful-
filled the criteria for informed consent described below.
For analysis, women were not added, moved from one village to another, or removed from
the list as a result of either temporary or permanent migration from the village where they
were initially registered. The only permitted additions to enrolment were women who newly
married into a trial village after enumeration (as ascertained in the monthly visits by the enu-
merators) and who were enrolled at that point.
Children. The protocol specified that children born to eligible women were to be included
in the primary trial analysis if their estimated delivery at enumeration was at least 6 months
after randomisation, to allow time for the interventions to be implemented and to have an
impact on neonatal mortality. In fact, the intervention took longer than anticipated to imple-
ment, and a decision was taken by the trial steering committee (TSC) in autumn 2008 (without
access to outcome data) to delay the date from which data would contribute to the analysis to 1
December 2008 (9.5 months after randomisation, and 4 months after first initiation of the
intervention).
Consent
State approval was obtained from the Andhra Pradesh Department of Health & Family Wel-
fare. Village consent was obtained from each panchayat (smallest unit of democratically
elected government in rural India). The trial protocol was explained to villagers in their local
language. Oral consent was given by the panchayat and sarpanch (panchayat leader) during a
meeting before randomisation, with written documentation of approval by the sarpanch.
Women provided oral consent at enumeration. Women who married into a trial village post-
randomisation were informed about the trial, and their consent obtained.
Randomisation
The villages were stratified by travel time to the nearest designated NPHC (less than or greater
than 1 hour) and tribal status (whether the village was a thanda [tribal village 2–3 km from the
main village, with around 15 families], a penta [tribal village 20–30 km from the main village,
with around 4–5 families], or non-tribal). Within each stratum, half the villages were allocated
to the intervention arm and half to the control arm by the LSHTM statistician using com-
puter-generated random numbers.
CHAMPION cluster randomised trial, Telangana, India
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Masking
After randomisation, participants, data collectors, and data analysts were not masked to alloca-
tion. Data collectors could not be masked as they were going into villages where the interven-
tions were obvious and collecting data from participants who were not masked. Given this
necessary lack of masking in the field, we felt that trying to ensure the masking of data analysts
would add complexity for little benefit. The regular communication between the data analysts
and the data collectors would have made such masking very difficult to implement. Further,
the anticipated large difference in health knowledge between the arms would have made the
randomisation clear.
Interventions
Intervention villages. A package consisting of community health promotion and provi-
sion of health services was delivered in the intervention villages. The intervention teams were
selected and managed by the NICE (Neonatal Intensive Care and Emergencies) Foundation
(http://nicefoundation.in/about.html). Members of the intervention team were responsible
for all service delivery activities in the intervention villages. Team members included a pro-
gramme coordinator who led the team and coordinated care with the NPHCs; 2 programme
officers who managed the field supervisors, midwives, and VHWs; field supervisors who were
responsible for community mobilisation, mainly via PDGs, and for monitoring the VHWs;
and midwives and VHWs. Regular intervention team meetings were held to share lessons
learned and for future planning.
Health promotion activities. Each intervention village received a health education cam-
paign during the trial. Folk culture (Kalajatha) in the form of song and dance was used to pro-
mote key maternal and child health themes. The intervention team worked with a group of
artists for a month to finalise the messages and ways to disseminate them. They produced the
final format after 2 pilot sessions in villages. The songs carried messages about safe maternal
and child health practices, focusing on clearing misconceptions about maternal and child
health, danger signs when pregnancies go wrong, trained birth assistance, safe motherhood,
newborn care, the advantages of institutional delivery, the importance of fixed day health ser-
vices (FDHSs), and the PDGs.
PDGs were conducted at least monthly and, in contrast to the health education campaign,
primarily targeted women to improve mothers’ and caretakers’ health knowledge, increase
each community’s awareness of maternal and child health, and encourage greater use of avail-
able health services, safe delivery techniques, and referral of high-risk women and babies to
more specialist centres. The PDGs also gave mothers a forum to discuss solutions to important
maternal and newborn health issues. Ten key discussion themes promoting good health prac-
tices including health service usage during and after pregnancy were repeated over the dura-
tion of the trial. These included recognising risk factors for baby and mother, drawing up birth
plans, safe delivery techniques, family health, and immunisation. Other issues that were
important in the villages were identified and delivered as a session. There was 1 PDG session
(module) per theme. Posters, flip charts, and flash cards were used, supplemented by examples
of actual foodstuffs at the nutrition session. Eligible women and other members of the commu-
nity could attend the sessions, which happened on the day of the FDHS. Each session lasted
approximately an hour and took place at a village venue suitable to most women. Sessions con-
tained icebreakers, a review of the previous meeting, and new themes, with reinforcement
through activities, demonstrations, and games.
Approximately 230 women were selected in consultation with the community and trained
to serve as VHWs. Although an option in the protocol was for VHWs to be auxiliary nurse
CHAMPION cluster randomised trial, Telangana, India
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midwives (ANMs) or traditional birth attendants, in practice none were. They were resident
women from or marrying into the village (‘daughter-in-laws of the village’), capable of reading
and writing in Telugu. Most had a 10th grade education.
Health service activities. The aim of the CHAMPION trial interventions was not to run a
parallel health service system but to strengthen existing government services, and so, where
possible, the trial intervention team converged with the government flagship programmes, for
instance, utilising ANM services to ensure tetanus vaccinations for pregnant women and
administering child vaccinations through the government ANMs. However, many of the gov-
ernment initiatives were not in place in the trial villages during the period of the trial (see Dis-
cussion). In their absence, VHWs were the primary contact point for the intervention team in
the village, responsible for delivering antenatal and health education in their allocated villages.
Their major role was to identify and track eligible women in their village, visiting the houses of
pregnant women and newborns, and documenting the events that occurred. They counselled
pregnant women and their family members, mobilised pregnant women to attend the FDHS,
supported midwives during the FDHS and provided follow-up care as advised by nurse mid-
wives, provided case briefings to the midwife at each FDHS consultation, and supported the
FDHS team in mobilising target audiences to PDG sessions. The VHWs were also involved in
preparation for, and conducting or assisting at, normal deliveries in the village and providing
follow-up care for postnatal women, including 3 visits during the first week, and 2 visits per
week from the second to fourth week. An important role involved tracking high-risk mothers
(identified based on vaginal bleeding; headache; persistent fever; abdominal cramps; dizziness;
loss of consciousness or blurring of vision; convulsions; shakes; shivering; poor circulation and
puffiness of the face, hands, or feet; lack of fetal movements over 4 hours; sudden weight gain or
loss; previous history of fetal loss; obstructed labour; or signs of malaria; S1 Text), as well as
detecting danger signs in newborns and facilitating timely referral and transport of pregnant
woman or newborns, if needed. VHWs were provided with mucous suckers, mackintosh sheets,
gauze pieces, rolls of cotton, brushes and antiseptic lotions (povidone-iodine for cord care),
birthing kits, weighing scales, measuring tapes, and fetoscopes. VHWs received payment propor-
tional to village size, to a maximum of 1,100 rupees for villages with close to 2,500 inhabitants.
VHWs underwent a 1-week residential training followed by quarterly 1-day refresher
training. The training topics included anaemia and complaints in pregnancy such as fever,
persistent headache, abdominal pain, and vaginal bleeding. VHWs were trained to monitor
potential breast problems, oedema, fetal heartbeat, and fetal movements. They were taught to
clinically assess fetal position, abnormal presentations, fundal height, and abnormal observa-
tions. The curriculum topics also included postnatal care, conducting safe home deliveries,
home-based newborn care practices, recognising danger signs in pregnant women and new-
borns, and arranging referrals. VHWs were taught how to monitor and document implemen-
tation of the intervention, and how to conduct PDG sessions. Training kits included manuals,
forms, flip charts, and delivery kits. Regular refresher sessions were held during the monthly
meetings, which reviewed any issues raised in the previous PDG meetings.
Sixteen qualified midwives visited intervention villages regularly throughout the trial.
Three were based at an NPHC. All midwives underwent a 10-day residential theoretical and
practical training conducted by experts in maternal and neonatal health. Every fortnight,
teams of 2 midwives (and a field supervisor) visited intervention villages and delivered the
FDHS. One midwife delivered the antenatal and postnatal health checks, including pregnancy
confirmation; assessment of fetal position; fundal height; gestational age; vaginal examination;
abnormal observations from physical examination and investigations such as haemoglobin
and urine analysis (sugar and albumin); and postnatal care and newborn care (head to foot
examination). The other midwife monitored the delivery of health education by the VHW.
CHAMPION cluster randomised trial, Telangana, India
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Midwives also accompanied women with high-risk pregnancies to the NPHCs, conducted
emergency deliveries at the village with the help of the VHWs, and, if needed in cases of com-
plications, were responsible for referring the mother/neonate in distress to the next level of
care accompanied by the VHW or the birth attendant.
Four NPHCs were identified to provide services that an expectant mother might require
during pregnancy and for the first month of her baby’s life. The NPHCs had approximately 20
beds, with facilities and a qualified doctor for normal deliveries and cesarean sections and a
paediatrician to see ‘problem’ newborns. NPHCs were selected based on criteria such as pro-
fessional competence, existing infrastructure, and public perception of the facility. An initial
contract of 3 months was agreed, after which favourable review led to a 6-month renewal.
These NPHCs were expected to provide around-the-clock service, admission to the general
ward, food for the patient and 1 attendant, and drugs and disposables to women from inter-
vention villages. This contract was subject to a per-patient cost ceiling. A rigorous monitoring
system implemented by the intervention team was part of the continuous quality assessment
process that buttressed against overbilling and over-provision of NPHC services. Transport
was not part of this contract, but 8 CHAMPION trial ambulances were provided by the NICE
intervention team directly at the village level to pick up and drop off patients at the NPHCs.
Women and their family members were also encouraged to use the emergency transport sys-
tem provided by the state government [30]. However, this transport system was not opera-
tional at the trial start, and only inconsistently thereafter.
All eligible women in the intervention villages were issued a health card (S1 and S2 Figs)
that tracked the various services they received under the programme, including immunisa-
tions, participation in health groups, regular check-ups, and hospitalisations.
Control villages. CHAMPION control villages were not offered the CHAMPION inter-
ventions. However, children between the ages of 6 and 9 years in 107 of the 232 CHAMPION
control villages were provided with the Naandi Foundation’s Ensuring Children Learn (ECL)
programme as part of a parallel trial (STRIPES [31]) utilising the same randomisation as in
CHAMPION, but with CHAMPION controls receiving ECL. A village was eligible for inclu-
sion in STRIPES if it was already participating in the CHAMPION trial, the village had at least
1 public primary school for both boys and girls, the school operated in the 2007–2008 aca-
demic year and was likely to continue operations during the following 2 years, and at least 15
children in total were present in classes 2, 3, and 4 in the school at the time of the baseline sur-
vey. Children were eligible for inclusion in the analysis of the trial if they were resident in an
eligible village, they were recorded in the enumeration conducted in January 2008 as planning
to be enrolled in class 2, 3, or 4 at the government school located in their village in the 2008–
2009 academic year, and if, after hearing an explanation of the trial, their parent(s) or guardian
(s) did not choose to opt out of the trial.
The remaining 125 CHAMPION control villages did not meet the eligibility requirements
for STRIPES but were nevertheless offered ECL outside the trial. A key purpose of implement-
ing ECL in the CHAMPION control villages was to give Naandi a presence in the control vil-
lages, hence helping to ensure that CHAMPION data collection was carried out to the same
standard in intervention and control villages. We anticipated that the primary-school-level
ECL educational intervention would not affect neonatal mortality in the control arm.
Outcomes
Primary outcome. The primary outcome for the trial was neonatal mortality defined as
death in the first 28 days of life of a live-born baby from a pregnancy (regardless of whether
singleton or multiple) with expected delivery date (EDD) on or after the assessment start date.
CHAMPION cluster randomised trial, Telangana, India
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Secondary outcomes. Secondary outcomes included age at neonatal death, and cause as
classified by verbal autopsy (VA) [32,33], and maternal mortality, defined as the death of a
woman during pregnancy or within 42 days of the end of pregnancy from any cause related to
or aggravated by the pregnancy or its management, among pregnancies with EDD on or after
the assessment start date (the cause was classified by VA [32]). Other outcomes included health
knowledge (including risk symptoms for neonates), health service usage (pregnancy care, care
at delivery, place of delivery, care after delivery), and satisfaction with care. The costs of the
interventions per life year saved (LYS) and per neonatal death averted are discussed in the eco-
nomic evaluation below. Neonatal and maternal morbidity were listed in the protocol as
potential outcomes, but, for logistical reasons, these data were not collected. Death in, or in
transit to, an NPHC was considered a serious adverse event.
Sample size
Making the simplifying assumption that each village had an average population of 659 [28]
with a birth rate of 23 per 1,000 population per year [25], 38 births per village over the trial
period were expected. Assuming an intra-cluster correlation coefficient (ICC) of 0.00644 [34]
for the primary outcome, 330 villages would give 80% power (5% 2-sided significance) to
detect a 25% reduction in neonatal mortality from 4.38% [28] to 3.29%. To account for possi-
ble migration (e.g., to their mother’s village around 1 to 3 months before the EDD and/or dur-
ing the summer to work in bigger towns) and for possible losses to follow-up, the target size
was increased to 464 villages.
Trial management
The trial was managed by a TSC and a trial management group (TMG). The TSC met periodi-
cally to discuss overall progress. The TMG met monthly to ensure efficient day-to-day running
of the trial. The Naandi Foundation was the local trial coordinating centre and was responsible
for the research components and data management in the field. The trial database was de-
signed and supported by Effective Intervention. LSHTM was responsible for all statistical
aspects. The NICE Foundation was subcontracted to implement the interventions.
Data collection
To reduce bias, the research/data collection team was selected and managed by the Naandi
Foundation and was independent of the intervention teams. While the research team could
not be masked to the intervention status of a village, they were trained to collect data in an
identical manner in the intervention and control villages. No data from the research team
were used by the intervention team.
The research team monitored and collected data about pregnant women and their babies in
both intervention and control villages. The team included a research coordinator who led the
team and was responsible for timely data entry; a research officer who validated the collected
data and monitored field staff; 19 data supervisors who monitored enumerators, supervised
the data collection process, obtained detailed follow-ups on pregnancy outcomes, and collected
information for VAs when necessary; 432 enumerators, to cover the 464 villages, who identi-
fied eligible women and tracked pregnancies; and data entry operators who were responsible
for data entry and generation of monitoring forms.
In each village, the enumerator conducted a monthly pregnancy check. The data were then
transported to Hyderabad, where all data were double-entered into a database, from which
forms were printed for the next monthly monitoring and taken to the field. If a woman was
identified as pregnant, the database triggered a follow-up form after the EDD. Data supervisors
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conducted a follow-up interview 6 weeks after delivery. Information about women who could
not be located or were known to have migrated beyond the trial area was sought through their
relatives in the village. If a live-born baby was suspected to have died aged 28 days or less, or a
woman known to be pregnant was suspected to have died during pregnancy or within 42 days
of the end of pregnancy, a specially trained data supervisor interviewed the family and com-
pleted a VA form to enable independent assessors to assign the primary cause of death. Data
about health knowledge, health practices including health service usage, and satisfaction with
care were collected by the research team for women with an eligible pregnancy.
Data supervisors visited enumerators monthly and cross-checked a sample of their reports.
The supervisors and enumerators met monthly at regional headquarters to deposit monthly
survey results, check that forms were properly completed, and discuss any problems in the
field. Flags were created in the database to check on inconsistencies or missing data in a timely
manner.
Statistical analysis
Primary analysis of outcomes followed the intention to treat principle.
As this trial has a complex hierarchical structure, with multiple women per cluster, poten-
tially multiple pregnancies per woman, and potentially multiple births per pregnancy, we used
a generalised estimating equations (GEE) analysis approach [35]. This approach assumes non-
independence of all observations from the same cluster, and so also accounts for non-indepen-
dence of multiple outcomes from the same woman.
For the primary outcome, the relative risk [36] with a 95% confidence interval was obtained
from a GEE model with a binary outcome, a log link, and a ‘working’ assumption of indepen-
dence as recommended by Lee and Nelder [37], with robust standard errors to take account of
clustering.
Although the protocol stated that we would not adjust for covariates in the primary analysis,
in the final statistical analysis plan we amended this so that the model included the stratifying
variables (travel time to nearest NPHC and tribal status of village). Secondary exploratory anal-
yses extended the relative risk model by adding an interaction between treatment arm and tim-
ing of enrolment (pre- versus post-randomisation) to assess the possibility of bias in the
primary outcome arising due to differential post-randomisation enrolment in the 2 arms. At
the request of a reviewer, an additional stratified analysis by whether or not control villages
were in the STRIPES trial was added.
The risk difference (and hence the estimated number of lives saved and the number needed
to treat) was estimated using the same model (without an interaction), but with an identity
rather than a log link. Although given as an option in the protocol, survival analysis was not
used because the period when neonatal death was possible was very short and the precise date
of death was not always known.
For secondary binary outcomes, relative risks were estimated using the same approach as
for the primary outcome. Other outcomes are reported descriptively but without statistical
testing due to the large number of comparisons.
Interim analyses were pre-specified and provided confidentially by the trial statisticians to
the independent data monitoring committee (DMC), which was guided by the Haybittle–Peto
rule [38].
Economic evaluation
A cost-effectiveness calculation in terms of cost per neonatal death averted and cost per LYS
was conducted. (Cost per disability-adjusted life year saved could not be considered as no
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measure of future disability was available.) The sensitivity of these outcomes to the most
important inputs—labour costs, fuel costs, and exchange rate movements—was examined.
The direct additional provider costs of the CHAMPION intervention activities compared
to existing standard of care in the control arm was measured. Total spending was cross-
checked with funding sources for accuracy. Spending was divided into running costs and capi-
tal costs. There were very limited start-up costs, which were assumed to be fully depreciated
during the trial, because the NICE Foundation had previously implemented a pilot version of
the programme elsewhere in India. Straight line depreciation of capital equipment (computers,
ambulances, refurbishment costs for public health centres, and medical equipment for these
clinics based on 3-, 4-, 6-, and 8-year lifespans, respectively) was allowed for, consistent with
usual account practices. Capital spending outside these items was depreciated immediately.
There were no contributions in kind. Office facility costs, which were shared with other proj-
ects managed by the Naandi Foundation, were allocated to the project according to estimated
share of usage (30%).
Annual cost figures were adjusted by India’s GDP deflator in order to convert values to
May 2011 rupees. Average exchange rates from May 2011 were used to convert rupee figures
to US dollars.
Results
Enumeration was carried out between August and November 2007, with randomisation on 18
February 2008. After an inception period, the intervention was initiated from 1 August 2008.
The assessment start date (see Methods) was 1 December 2008. The DMC met by teleconfer-
ence to review interim analyses on 2 occasions but did not recommend early stopping. The
intervention ended on 31 May 2011. Data collection was completed on 30 November 2011.
In the 464 villages, 20,282 enumerated women met the eligibility criteria (9,871 in control
and 10,411 in intervention villages, a difference attributable to chance). Non-eligibility was
mainly due to sterilisation. A further 9,387 newly married women were enrolled in the trial vil-
lages—more in intervention villages (4,266 control, 5,121 intervention). The total number of
enrolled eligible women was thus 14,137 control and 15,532 intervention (Fig 1; S1–S4 Datas).
Based on all 464 villages, the number of births per village varied between 0 and 141
(median = 28, interquartile range [IQR] Q1 = 12, Q3 = 49); 17 villages (6 control, 11 interven-
tion) had no live births during the assessment period (3 had stillbirths but no live births, and
the other 14 had either only miscarriages or abortions or had no confirmed pregnancies
[where a confirmed pregnancy was defined as either a live birth or a death where the preg-
nancy was confirmed by verbal autopsy]). Based on the 447 villages with at least 1 live birth,
the number of live births per village varied between 1 and 92 (median = 21, IQR Q1 = 9,
Q3 = 37) in the intervention villages and between 1 and 98 (median = 18, IQR Q1 = 7,
Q3 = 31) in the control villages. In all, 4,885 (34.6%) of the control village women had 5,474
confirmed pregnancies with an EDD of 1 December 2008 or later, and gave birth to 4,998 eligi-
ble children. The corresponding numbers in the intervention villages were 5,664 (36.5%)
women, 6,351 pregnancies, and 5,798 children.
Comparability of control and intervention villages is shown in Table 1 (see also S1 and S5–
S7 Datas). None of the control villages and 224 of the 232 intervention villages received at least
some of the intervention. There were no or very few women residing permanently in the 8
remaining villages due to seasonal migration specific to the tribal communities.
Between 1 August 2008 and 31 May 2011, 9,939 PDGs were held in the intervention vil-
lages, at least monthly, and 12,195 FDHSs were conducted during the trial. The total number
of pregnant women who attended the FDHSs was 4,492, against a potential number of 5,022.
CHAMPION cluster randomised trial, Telangana, India
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Fig 1. Flowchart: Clusters, women, and children at trial entry and in final analysis.
https://doi.org/10.1371/journal.pmed.1002324.g001
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Of the 4 NPHCs, 2 were managed by local private doctors, and 1 by midwives hired by the
intervention team (with paediatric support available); the contract with the fourth was termi-
nated due to quality concerns after supervisory visits, and the team referred cases to another
NPHC. Over this period, there were 913 referrals (526 maternal and 387 neonatal—290 from a
village to an NPHC or government facility, 429 from an NPHC to a tertiary care facility, and
194 from one NPHC to another or from a government facility to an NPHC or to a tertiary care
centre); 24% of deliveries in the intervention arm occurred at one of the NPHCs, 21% at home,
29% at government-related facilities, and 28% at private facilities. In the control villages, 21%
of deliveries were at home, 30% at government-related facilities, and 47% at private facilities.
Of the 11,945 children with an EDD of 1 December 2008 or later, 1,149 (602 in the inter-
vention arm, 547 in the control arm) were stillborn or died earlier in the pregnancy. Of the
live-born babies, 343 out of 4,998 (6.9%) in the control arm died in their first 28 days of life,
and 303 out of 5,798 (5.2%) in the intervention arm (risk ratio 0.76, 95% CI 0.64 to 0.90,
p = 0.0018; Table 2; S1, S9 and S10 Datas; risk difference −1.59%, 95% CI −2.63% to −0.54%),
Table 1. Comparability between trial arms.
Characteristic Subcategory Arm
Control Intervention
Villages N = 232 N = 232
Tribal status, n (percent) Non-tribal 136 (58.6) 135 (58.2)
Penta 21 (9.1) 20 (8.6)
Thanda 75 (32.3) 77 (33.2)
Travel time to NPHC, n (percent) <60 minutes 176 (75.9) 176 (75.9)
>60 minutes 56 (24.1) 56 (24.1)
Women giving birth during the period of the trial (with EDD on or after the ASD) N = 4,885 N = 5,664
Age of woman (years), mean (SD) 21.2 (3.9) 21.3 (3.9)
Education of woman, n (percent) Missing 304 322
No education 2,654 (57.9) 3,146 (58.9)
1–4 years 465 (10.2) 457 (8.6)
5–7 years 527 (11.5) 646 (12.1)
8+ years 935 (20.4) 1,093 (20.5)
Education of spouse, n (percent) Missing 403 431
No education 2,009 (44.8) 2,336 (44.6)
1–4 years 326 (7.3) 378 (7.2)
5–7 years 695 (15.5) 823 (15.7)
8+ years 1,452 (32.4) 1,696 (32.4)
Previous miscarriage, n (percent) 1,157 (25.3) 1,372 (25.7)
Neonatal deaths in the last year, n (percent based on births in the last year) 59 (5.8)
(N = 1,023)
74 (6.7)
(N = 1,106)
Pregnancies during the period of the trial resulting in a birth (with EDD on or after the
ASD)
N = 5,466 N = 6,347
Multiplicity of birth, n (percent) Singleton 5,388 (98.6) 6,295 (99.2)
Twin 77 (1.4) 51 (0.8)
Triplet 1 (0.02) 1 (0.02)
Children born during the period of the trial (with EDD on or after the ASD) N = 5,545 N = 6,400
Sex, n (percent) Male 2,552 (46.0) 3,011 (47.0)
Female 2,446 (44.1) 2,788 (43.6)
Not known 547 (9.9) 601 (9.4)
ASD, assessment start date; EDD, expected delivery date; NPHC, non-public health centre.
https://doi.org/10.1371/journal.pmed.1002324.t001
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suggesting 92 fewer deaths (95% CI 31 to 152) as a result of the intervention. The ‘number
needed to treat’ to prevent 1 neonatal death was 63 (95% CI 38 to 185). The babies in the con-
trol arm were more likely to die in the first week of life, but there were no clear differences
between trial arms in terms of sex or cause of death.
In exploratory analyses the effect of the intervention on neonatal mortality did not differ
significantly by travel time to the nearest NPHC (interaction test p = 0.6516) or by tribal status
of village (interaction test p = 0.3538). Nor was there a significant interaction by whether the
village participated in the STRIPES education trial (interaction p = 0.2876) or according to
timing of enrolment (investigated to assess the possibility of bias in the primary outcome due
to differential post-randomisation enrolment between the 2 arms; pre-randomisation versus
newly married post-randomisation, p = 0.1552). Table 3 shows the results in these strata (see
also S1 and S11 Datas).
The estimated design effect for neonatal mortality was 1.306. There are complexities with
defining an ICC for neonatal mortality in this study. The ICC has a simple definition only for
a continuous outcome with a 2-level hierarchy. Here there is a 4-level hierarchy (potentially
multiple children per pregnancy, multiple pregnancies per woman, and multiple women per
village), and the outcome is binary (even for a 2-level hierarchy there are a number of different
definitions of the ICC for a binary outcome [39], which can differ quite markedly). Ignoring
these difficulties and estimating the ICC from the design effect and the mean number of live
births per village (25.74) via the usual formula gives an estimated ICC of 0.012.
Table 2. Neonatal mortality for births with expected delivery date after the assessment start date.
Outcome Control arm (N = 5,545) Intervention arm (N = 6,400) Risk ratio (95% CI)
Dead at birth or pregnancy loss 547 (9.9) 602 (9.4)
Alive at birth 4,998 (90.1) 5,798 (90.6)
Alive at 28 days 4,655 (93.1) 5,495 (94.8)
Neonatal death 343 (6.9) 303 (5.2) 0.76 (0.64 to 0.90)
Neonatal death: age at death
Within first day 83 (24.2) 65 (21.5)
1–7 days 189 (55.1) 156 (51.5)
8–28 days 56 (16.3) 63 (20.8)
Not known 15 (4.4) 19 (6.3)
Neonatal death: gender
Female 156 (45.5) 147 (48.5)
Not known 5 (1.5) 4 (1.3)
Neonatal death: cause of death
Congenital anomaly 31 (9.0) 21 (6.9)
Multiple birth 26 (7.6) 13 (4.3)
Maternal disease 44 (12.8) 32 (10.6)
Specific fetal condition 4 (1.2) 3 (1.0)
Small-for-date infant 19 (5.5) 15 (5.0)
Placental abruption 3 (0.9) 2 (0.7)
Obstetric complication 59 (17.2) 54 (17.8)
Specific infant condition 61 (17.8) 63 (20.8)
Asphyxia 40 (11.7) 31 (10.2)
Immaturity 33 (9.6) 31 (10.2)
Not known 23 (6.7) 38 (12.5)
Data are given as n (percent).
https://doi.org/10.1371/journal.pmed.1002324.t002
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Table 4 shows maternal mortality based on pregnancies with an EDD of 1 December 2008
or later (see also S1 and S12 Datas). There were 9 (0.16%) deaths in the control arm compared
to 13 (0.20%) in the intervention arm (risk ratio 1.24, 95% CI 0.53 to 2.90, p = 0.6176). In both
arms, the main causes were haemorrhage and hypertensive disorders, although there were also
cases of sepsis, obstructed labour, and other pregnancy-related conditions in the intervention
arm.
Harms potentially related to the CHAMPION intervention
One serious adverse event was reported in October 2008. Following a trial of labour at an
NPHC, a woman died after transfer in a CHAMPION trial ambulance to a private hospital on
her family’s wishes.
Health knowledge, health practices including health service usage, and
satisfaction with care
Based on women with pregnancies that resulted in a live birth with EDD on or after the assess-
ment start date, a higher proportion of women in the intervention arm than in the control arm
gave correct answers on 20 out of 23 health knowledge items when asked about risk symptoms
for neonatal problems (Table 5; S1 and S13 Datas).
Table 3. Neonatal mortality according to characteristics of villages/women for births with expected delivery date after the assessment start date.
Characteristics Control arm Intervention arm Risk ratio (95% CI)
Travel time from village to nearest NPHC
<60 minutes 289/4,200 (6.9) 252/4,868 (5.2) 0.75 (0.62, 0.90)
>60 minutes 54/798 (6.8) 51/930 (5.5) 0.84 (0.53, 1.33)
Tribal status of village
Non-tribal 260/3,995 (6.5) 237/4,652 (5.1) 0.78 (0.64, 0.95)
Penta 12/93 (12.9) 6/116 (5.2) 0.39 (0.17, 0.91)
Thanda 71/910 (7.8) 60/1,030 (5.8) 0.74 (0.51, 1.08)
STRIPES trial participation
Village in STRIPES trial 226/3,502 (6.5) 216/4,145 (5.2) 0.81 (0.67, 0.99)
Village not in STRIPES trial 117/1,496 (7.8) 87/1,653 (5.3) 0.66 (0.48, 0.91)
Timing of enrolment
Woman recruited pre-randomisation 221/3,368 (6.6) 200/3,697 (5.4) 0.83 (0.67, 1.02)
Woman recruited post-randomisation 122/1,630 (7.5) 103/2,101 (4.9) 0.65 (0.49, 0.86)
Data are given as n/N (percent).
NPHC, non-public health centre.
https://doi.org/10.1371/journal.pmed.1002324.t003
Table 4. Maternal mortality for pregnancies with expected delivery date after the assessment start date.
Outcome Arm Risk ratio (95% CI)
Control (N = 5,474) Intervention (N = 6,351)
Maternal deaths, n (percent) 9 (0.1644) 13 (0.2047) 1.24 (0.53 to 2.90)
Cause of death, n
Haemorrhage 5 3
Sepsis 0 2
Hypertensive disorders 4 3
Obstructed labour 0 3
Other pregnancy-related conditions 0 2
https://doi.org/10.1371/journal.pmed.1002324.t004
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Women with pregnancies with EDD on or after the assessment start date were asked about
antenatal, delivery, and postnatal care experiences (although it was usually felt insensitive to
ask these question of women whose deliveries did not lead to a live birth). Women in the inter-
vention arm were more likely to have attended more antenatal care, with more testing and
Table 5. Mothers’ knowledge of risk symptoms for neonates (based on pregnancies that resulted in a live birth with estimated delivery date on or
after the assessment start date).
Health knowledge item Control arm (N = 4,935) Intervention arm (N = 5,757)
List signs of anaemia1
Pale nails 1,116 (22.6) 1,903 (33.1)
Pale palms 779 (15.8) 1,281 (22.3)
Pale eyelids 1,188 (24.1) 1,936 (33.6)
Tiredness 1,469 (29.8) 1,600 (27.8)
Missing 3 (0.06) 3 (0.05)
List signs of an emergency delivery1
Breech 359 (7.3) 988 (17.2)
Water broke 529 (10.7) 885 (15.4)
Heavy bleeding 277 (5.6) 438 (7.6)
Green or brown waters 56 (1.1) 66 (1.2)
Mother has fever 94 (1.9) 213 (3.7)
Missing 3 (0.08) 3 (0.05)
Options if baby develops diarrhoea
Breastfeed more frequently and try to make the baby drink more2 1,277 (25.9) 1,498 (26.1)
Breastfeed when the child would like to, but don’t make any special efforts 2,673 (54.2) 3,099 (53.9)
Wait for a short while until the diarrhoea settles down and then breastfeed again 481 (9.8) 516 (9.0)
Wait for quite a long time until you are sure the diarrhoea has stopped and then breastfeed again 280 (5.7) 406 (7.1)
Missing 7 (0.14) 10 (0.17)
List signs of dehydration in newborn1
Reduced urinating 50 (1.0) 138 (2.4)
Reduced tears 76 (1.5) 137 (2.4)
Dry mouth and lips 654 (13.3) 902 (15.7)
Sunken eyes 1,589 (32.2) 1,793 (31.2)
Sunken fontanelle 55 (1.1) 111 (1.9)
Missing 3 (0.06) 3 (0.05)
List signs of neonatal sepsis1
Reduced sucking 13 (0.3) 34 (0.6)
Drowsy or unconscious 8 (0.2) 22 (0.4)
Cold to touch 8 (0.2) 14 (0.2)
Fever 358 (7.3) 666 (11.6)
Breathing fast 252 (5.1) 441 (7.7)
Chest is indrawing 10 (0.2) 35 (0.6)
Grunting 138 (2.8) 404 (7.0)
Skin infection or infection in umbilical cord 194 (3.9) 281 (4.9)
Missing 3 (0.06) 3 (0.05)
Data given as the number (percent) of respondents stating a given sign or course of action.
1Not mutually exclusive options; all correct responses are listed. These questions were free response, and women answered only what they knew without
prompting.
2This is the correct option.
https://doi.org/10.1371/journal.pmed.1002324.t005
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Table 6. Antenatal, delivery, and postnatal care experience of women with pregnancies with estimated delivery date on or after the assessment
start date.
Question Answer Control arm (N =
5,474)
Intervention arm (N =
6,351)
How many antenatal visits did you have? 1 to 5 1,619 (33.2) 593 (12.1)
6 to 10 2,275 (46.6) 1,890 (38.7)
11 988 (20.3) 3,252 (66.6)
Missing 63 29
Not asked1 529 587
Were you weighed? Yes 4,354 (89.2) 5,628 (98.2)
Missing 64 30
Not asked1 530 587
Was your blood pressure taken? Yes 4,613 (94.5) 5,687 (99.2)
Missing 64 30
Not asked1 530 587
Did you give a urine sample? Yes 4,424 (90.6) 5,572 (97.2)
Missing 64 30
Not asked1 529 587
Did you give a blood sample? Yes 4,422 (90.6) 5,562 (97.0)
Missing 64 30
Not asked1 530 587
Was your abdomen checked? Yes 4,608 (94.4) 5,676 (99.0)
Missing 64 30
Not asked1 530 587
Were you told your delivery date? Yes 4,193 (85.9) 5,295 (92.3)
Missing 64 30
Not asked1 530 587
Did you receive a tetanus shot? Yes 4,811 (97.5) 5,664 (98.4)
Missing 10 6
Not asked1 528 587
Did you receive iron/folic acid? Yes 4,758 (96.4) 5,649 (98.1)
Missing 10 5
Not asked1 528 587
Who assisted delivery?2 Doctor 2,278 (46.2) 2,796 (56.7)
ANM/nurse/midwife/LHV 3,618 (73.4) 4,453 (90.3)
Other health personnel 159 (3.2) 247 (5.0)
Traditional birth attendant 918 (18.6) 971 (19.7)
Friend/relative 2,351 (47.7) 2,485 (50.4)
Other 400 (8.1) 365 (7.4)
Nobody 9 (0.2) 7 (0.1)
Missing 11 6
Not asked1 533 592
Where did you give birth? Home (yours, your parents, other) 1,053 (21.4) 1,022 (17.8)
Public facility 1,512 (30.5) 1,689 (29.3)
Private facility 2,315 (47.0) 1,615 (28.1)
CHAMPION NPHC 2 (0.04) 1,362 (23.6)
Other 47 (1.0) 65 (1.1)
Missing 11 6
Not asked1 534 592
(Continued )
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Table 6. (Continued)
Question Answer Control arm (N =
5,474)
Intervention arm (N =
6,351)
Did you arrive before, during, or after delivery? Before 552 (14.4) 615 (13.2)
During 3,276 (85.6) 4,047 (86.8)
After 1 (0.0) 2 (0.0)
Missing 1,109 1,094
Not asked1 536 593
What transport did you have to the facility?2 CHAMPION trial ambulance 5 (0.1) 466 (12.2)
Paid private transportation 2,795 (73.0) 2,948 (77.0)
Emergency government transport 1,044 (27.3) 1,422 (37.1)
Walked 134 (3.5) 217 (5.7)
Other 39 (1.0) 39 (1.0)
Missing 1,109 1,092
Not asked1 535 593
What was the mode of delivery? Vaginal cephalic 3,571 (72.3) 4,087 (71.0)
Vaginal breech 6 (0.1) 10 (0.2)
Cesarean section 1,357 (27.5) 1,656 (28.8)
Instrumental (forceps/vacuum) 2 (0.0) 2 (0.0)
Missing 9 7
Not asked1 529 589
What was used to cut the umbilical cord? Knife 5 (0.3) 3 (0.2)
Scissors 345 (19.9) 373 (20.0)
Razor (new) 1,348 (78.0) 1,452 (78.0)
Sickle 14 (0.8) 2 (0.1)
Stone 2 (0.1) 6 (0.3)
Razor (old) 13 (0.8) 16 (0.9)
Other 2 (0.1) 9 (0.5)
Missing 3,207 3,894
Not asked1 537 595
For deliveries where an instrument was used: How were any
surgical instruments cleaned?2
Placed in boiling water 91 (1.7) 111 (1.7)
Wiped with alcohol solution 36 (0.7) 22 (0.3)
Placed over open flame 0 (0.0) 0 (0.0)
Wiped clean 209 (3.8) 227 (3.6)
Other 23 (0.4) 20 (0.3)
Don’t know 309 (5.7) 368 (5.8)
What was used to dress the umbilical cord? Cow dung 1 (0.0) 0 (0.0)
Turmeric 1,363 (28.3) 1,172 (20.9)
Tobacco 4 (0.1) 3 (0.1)
Antiseptic 1,694 (35.2) 2,346 (41.8)
Ash 2 (0.0) 0 (0.0)
Nothing 1,373 (28.5) 1,658 (29.5)
Other 376 (7.8) 440 (7.8)
Missing 127 141
Not asked1 533 590
Delivery procedures: Was a disposable kit used? Yes 3,744 (78.2) 4,407 (80.5)
Missing 154 288
Not asked1 530 589
(Continued )
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advice; have trained personnel at delivery; deliver in an institution; have antiseptic dressing for
the umbilical cord; have their baby wiped and weighed; initiate breastfeeding soon after birth;
and have trained personnel for postnatal checks (Table 6; S1 and S14 Datas). Women in the
intervention arm were more likely to rate their delivery and postnatal care as good or very
good (Table 7; S1 and S15 Datas).
Economic evaluation
The total cost of the CHAMPION interventions (US$1,084,955) was divided into spending on
the clinical programme (63.4%—mainly financing mobile clinics, midwives, and emergency
services, with around a quarter for the NPHCs), spending on the community mobilisation pro-
gramme (mainly via PDGs; 20.2%), and administration costs (16.4%). Wages were 60% of total
costs (Table 8). The total costs translate into a cost of US$11,769 per life saved (95% CI $7,115
to $34,653).
Though there were substantial distances between intervention villages due to the trial
design, fuel costs represented only 9% of total costs. Since all costs were local, exchange rate
movements have a one-to-one impact on cost-effectiveness measures when converted to
dollars.
Life expectancy at birth for those living in rural AP was reported as 68.3 years [28] and, dis-
counted at 3%, implies 28.8 LYS per child saved, giving a cost of US$409 (95% CI $247 to
$1,203) per LYS (Table 9).
Discussion
The CHAMPION trial showed that a package of interventions addressing health knowledge
and health seeking behaviour, buttressing existing health services, and contracting out impor-
tant areas of maternal and child healthcare led to almost the hypothesised 25% reduction in
neonatal mortality in small villages in an Indian state with high mortality rates. This was in
Table 6. (Continued)
Question Answer Control arm (N =
5,474)
Intervention arm (N =
6,351)
Delivery procedures: Was the baby wiped and wrapped? Yes 2,892 (62.4) 3,765 (69.8)
Missing 311 370
Not asked1 531 589
Was the baby weighed at birth? Yes 3,667 (75.9) 4,595 (80.9)
Missing 111 85
Not asked1 533 589
Was the baby breastfed? Yes 4,711 (95.5) 5,668 (96.8)
Missing 8 5
Not asked1 531 591
For all those breastfed: When was breast feeding initiated? Immediately or within half an hour
after birth
6 (0.2) 7 (0.1)
Hours after birth 2,761 (58.6) 3,509 (63.1)
Days after birth 1,941 (41.2) 2,049 (36.8)
Missing 3 3
1Not asked because it was usually felt insensitive to ask these questions of women whose deliveries did not lead to a live birth.
2Categories not mutually exclusive.
ANM, auxiliary nurse midwife; LHV, lady health visitor; NPHC, non-public health centre.
https://doi.org/10.1371/journal.pmed.1002324.t006
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 19 / 28
Table 7. Satisfaction with care (based on pregnancies with estimated delivery date on or after the assessment start date).
Item Answer Control arm (N = 5,474) Intervention arm (N = 6,351)
Reasons for not being fully satisfied with healthcare in pregnancy1,2 Cost too much 1,603 (32.5) 1,625 (28.2)
Facility not open 405 (8.2) 349 (6.1)
Too far/transportation 1,696 (34.3) 1,887 (32.8)
Don’t trust facility 558 (11.3) 699 (12.1)
No female provider at facility 11 (0.2) 12 (0.2)
Husband/family did not allow the full receipt of
care
11 (0.2) 9 (0.2)
Not necessary 55 (1.1) 27 (0.5)
Not customary 4 (0.1) 12 (0.2)
Other 3,791 (76.8) 4,366 (75.8)
Not relevant, as fully satisfied 38 (0.8) 191 (3.3)
Missing 8 5
Not asked3 528 587
Women’s rating of healthcare at delivery Very bad 4 (0.1) 14 (0.3)
Bad 779 (15.8) 725 (14.7)
Good 4,113 (83.4) 4,667 (94.6)
Very good 35 (0.7) 342 (6.9)
Missing 12 15
Not asked3 531 588
Reasons for not being fully satisfied with healthcare at delivery1,2 Cost too much 1,833 (37.1) 1,416 (24.6)
Facility not open 502 (10.2) 476 (8.3)
Too far/transportation 1,557 (31.5) 1,751 (30.4)
Don’t trust facility/poor quality service 915 (18.5) 1,048 (18.2)
No female provider at facility 72 (1.5) 80 (1.4)
Husband/family did not allow the full receipt of
care
13 (0.3) 15 (0.3)
Not necessary 38 (0.8) 37 (0.6)
Not customary 3 (0.1) 7 (0.1)
Other 3,729 (75.5) 4,240 (73.6)
Not relevant, as fully satisfied 45 (0.9) 359 (6.2)
Missing 11 11
Not asked3 530 587
Women’s rating of healthcare 28 days post-delivery Very bad 5 (0.1) 17 (0.3)
Bad 508 (10.3) 473 (8.2)
Good 4,383 (88.9) 5,107 (88.8)
Very good 35 (0.7) 151 (2.6)
Missing 12 15
Not asked3 531 588
Reasons for not being fully satisfied with healthcare 28 days post-
delivery1,2
Cost too much 938 (19.0) 1,049 (18.2)
Facility not open 385 (7.8) 339 (5.9)
Too far/transportation 1,226 (24.8) 1,509 (26.2)
Don’t trust facility/poor quality service 505 (10.2) 620 (10.8)
No female provider at facility 41 (0.8) 46 (0.8)
Husband/family did not allow the full receipt of
care
10 (0.2) 6 (0.1)
Not necessary 172 (3.5) 162 (2.8)
Not customary 3 (0.1) 6 (0.1)
Other 3,955 (80.1) 4,588 (79.7)
Not relevant, as fully satisfied 57 (1.2) 173 (3.0)
Missing 11 11
Not asked3 530 587
1Categories not mutually exclusive.
2Answers were free response (not multiple choice).
3Not asked because it was usually felt insensitive to ask these questions of women whose deliveries did not lead to a live birth.
https://doi.org/10.1371/journal.pmed.1002324.t007
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spite of large secular reductions (over 30%) in neonatal mortality in rural India over recent
decades [40] (although the rate was still higher than assumed in the initial power calculations).
Possible mechanisms for the excess reduction in the intervention arm may relate to the fact
that women became more knowledgeable about risk symptoms for neonatal problems; had
drawn up a specific birth plan; were proactively monitored, with appropriate referral and
other actions; had the support of trained personnel available at delivery; had standardised care
at the NPHCs; had antiseptic care for the umbilical cord; and initiated breastfeeding sooner
than those in the control arm, However, the intervention was a ‘package’, and, while we could
postulate particular causes for the large reduction, it is not possible to completely disentangle
these in post hoc analyses. The benefits of the CHAMPION interventions were conservatively
assumed to be limited to the 30 months for which statistical analysis of mortality was con-
ducted. However, some of the intended benefits of this project are in terms of behaviour
change and knowledge, which may have longer-term effects.
There were no clear effects of the intervention on maternal mortality, but the number of
deaths meeting the WHO definition of deaths due to maternal causes over the period of the
trial was low, and the confidence interval was wide. The rates were compatible with recent fig-
ures from AP [27].
The strengths of the study include its cluster RCT design, its size, and its focus on contract-
ing out high-quality services. For instance, a team of doctors from the intervention team
reviewed the quality of the care provided by NPHCs using stringent criteria before funds were
released.
The potential for bias was reduced by separation of the research and intervention teams.
They were housed in separate offices, did not train together or work together, were explicitly
Table 8. Costs by category (calculated in May 2011 US dollars).
Category Cost (US dollars) Percent of total cost
Clinical programme 687,377 63.4
Coordinators, supervisors, and consultants 123,647 11.4
Midwives, field staff, and other personnel 159,317 14.7
Vehicles and fuel: ambulances and mobile clinics 155,165 14.3
Staff transport and other miscellaneous costs 20,220 1.9
Materials 44,021 4.1
Referral services 178,146 16.4
Public health centre refurbishments 6,183 0.6
Other 675 0.1
PDGs and other community mobilisation 219,209 20.2
Supervisors and consultants 4,446 0.4
Village health workers 205,094 18.9
Events and campaigns 4,592 0.4
Other 5,078 0.5
Administration 178,370 16.4
Personnel 147,311 13.6
Materials 11,257 1.0
Capital costs 2,847 0.3
Other 16,954 1.6
Total cost 1,084,955 100.0
PDG, participatory discussion group.
https://doi.org/10.1371/journal.pmed.1002324.t008
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urged against communicating except when absolutely necessary, and had entirely separate
reporting structures.
Villages in the control arm also received an active intervention (for primary-school-age
children [31]) to reduce potential disappointment and increase the likelihood of receiving
equally good quality data in both trial arms.
The 3-level consent process was agreed to by the relevant research ethics committees in
2007, and would also meet recent guidelines [41] for cluster RCTs.
A limitation of the study is that it could not be masked post-randomisation. It seems
unlikely, however, that this led to ascertainment bias in the mortality outcomes given that
these are ‘hard’ endpoints, and because of the training given to the data collectors and the stan-
dardised approaches used in the VAs. Also, if there was a bias in favour of the intervention vil-
lages, this might be expected to apply to both mortality outcomes, not only neonatal mortality.
A second limitation is that fetal losses were not divided into stillbirths and miscarriages
based on gestational age, both because gestational age was not reliably reported and because of
potential biases, as women in the intervention arm may have reported pregnancies earlier than
control women. However, rigorous training was conducted to help data collectors to distin-
guish between neonatal and fetal losses.
Proportionately more women were recruited in the trial post-randomisation in the inter-
vention arm, which might reflect women wishing to access the intervention package. While it
seems implausible that women would marry into a village purely for that reason, the implica-
tions were nevertheless explored by an analysis of the interaction of arm with timing of enrol-
ment, which was found to be significant.
It is possible that the effects of the intervention could have been diluted by other changes
during the trial period, as the government introduced other maternal and child health pro-
grammes, including incentives to encourage institutional deliveries and care. Facility-based
newborn care increased with the introduction of 2 government initiatives: the Janani Suraksha
Yojna (JSY), a cash transfer incentive scheme for promoting institutional deliveries introduced
in 2005, and the Janani Shishu Suraksha Karyakram, a free maternity and newborn pro-
gramme in all government healthcare institutions introduced in 2011 under the National
Rural Health Mission [42]. One of the key elements of the National Rural Health Mission is
the involvement of the ASHAs. The CHAMPION trial cooperated with ASHAs in our villages
when possible, but their presence and authority on maternal and child health was not fully
established in most of our villages until well after the end of the trial. During the trial and after-
wards, due partly to lack of manpower, blood storage facilities, and referral linkages, the public
Table 9. Indicators of cost-effectiveness.
Indicator Value 95% Confidence Interval
Total cost $1,084,955
Number of deaths averted 92.19 31.31 to 152.49
Life years saved (64.3 years life expectancy, 3% discount rate, 28.8 years per life saved) 2,655 901 to 4,391
Cost per life saved $11,769 7,115 to 34,653
Cost per life year saved (3% annual discount rate) $409 247 to 1,203
Annual cost per population $2.41
Annual cost per eligible-aged woman $14.63
Cost per live birth $102.14
Costs given in May 2011 US dollars.
https://doi.org/10.1371/journal.pmed.1002324.t009
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sector was often not in a position to provide emergency obstetric care services [43–47]; major
problems were transportation distances and difficult terrains. The services offered under the
CHAMPION trial improved access to maternal and newborn healthcare services that were not
easily available to the marginalised populations living in difficult-to-reach villages.
As the aim of the CHAMPION trial interventions was not to run a parallel system, there
was constant dialogue between personnel from the public health system and the trial interven-
tion team to ensure that care of pregnant women and their babies did not fall between the
gaps. Women delivering in private health facilities did not normally come under the ambit of
the JSY scheme. However, those registered in the CHAMPION intervention villages could
choose either the nearest government health facility or the NPHCs; many women with high-
risk pregnancies opted for the NPHC, and an agreement was reached with government offi-
cials that women who gave birth at the NPHCs would be eligible to receive the JSY. Although
not asked specifically about JSY, 85% of respondents in both the intervention and control
arms said they expected to receive a subsidy.
The CHAMPION interventions may have reduced the demands on public health services,
although the trial did not collect adequate usage and cost data to estimate the scale of this.
Compared to similar interventions in India [48,49], the CHAMPION trial focused more on
outreach services in the community, encouraging the majority of women to continue using
existing care.
Recent reviews [50,51] seem to support the conclusions from the CHAMPION trial, in par-
ticular ‘the value of integrating maternal and newborn care in community settings through a
range of interventions, which can be packaged effectively for delivery through a range of com-
munity health workers and health promotion groups’ [50].
In terms of the economic evaluation, investigators in a systematic review of cluster RCTs of
women’s group interventions in India and Africa [52] found that the incremental cost per life
saved ranged from $2,770 to $22,971 (2011 US dollars). In several cases, their costs were lower
than the costs reported here; however, these other trials did not provide additional clinical ser-
vices nor train VHWs. The CHAMPION trial was not able to determine the relative impor-
tance of the clinical services compared to the discussion groups offered. It is possible that there
may be returns to scale that could further reduce the CHAMPION intervention costs, but total
costs are most sensitive to wages (60% of total costs), and a scale-up of this project would not
save on personnel and would not therefore lower costs significantly.
A cost-effectiveness ratio per LYS of double the local income per capita can be considered a
threshold for public support [53]. This equates to US$3,180 in India (income per capita in
India being US$1,590 in 2011). The cost per LYS of the CHAMPION intervention is approxi-
mately one-tenth of this threshold, suggesting that the intervention can be strongly justified on
economic grounds. Given the successful results of the CHAMPION and STRIPES trials, we
are continuing the interventions for a further 5 years, and scaling up the intervention to
include all control villages.
In terms of generalisability, it is likely that the CHAMPION intervention can be strongly
justified in much of rural India with disadvantaged populations (but with the work of the
CHAMPION trial VHWs now being done by the ASHAs), and is of potential use in rural set-
tings in other countries with similar socioeconomic and cultural patterns, similar neonatal
mortality profiles, and the existence of some private health provision. Ongoing changes in
maternal and child health programmes, both during the period of the trial and subsequently,
make it imperative that a similar intervention that establishes ties between the community and
health facilities is tested in different settings. We are in the process of designing a similar trial
in a different region of India.
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 23 / 28
Supporting information
S1 Data. Directory.
(XLS)
S2 Data. Flow chart for women.
(CSV)
S3 Data. Flow chart for pregnancies.
(CSV)
S4 Data. Flow chart for children.
(CSV)
S5 Data. Comparability of villages.
(CSV)
S6 Data. Comparability of women.
(CSV)
S7 Data. Comparability of multiple births.
(CSV)
S8 Data. Comparability by sex.
(CSV)
S9 Data. Neonatal deaths.
(CSV)
S10 Data. Cause of neonatal deaths.
(CSV)
S11 Data. Neonatal deaths by stratum.
(CSV)
S12 Data. Maternal mortality.
(CSV)
S13 Data. Risk symptoms for neonates.
(CSV)
S14 Data. Care experience.
(CSV)
S15 Data. Satisfaction with care.
(CSV)
S1 Fig. Antenatal card: Front.
(JPG)
S2 Fig. Antenatal card: Rear.
(JPG)
S1 Text. Risk assessment criteria.
(DOCX)
S2 Text. CONSORT checklist.
(DOCX)
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 24 / 28
Acknowledgments
We would like to thank all the women and their families who took part in the trial; the indepen-
dent DMC (G. Piaggio, L. Wright, S. Goudar); Rakhi Nair and M. J. Wesley (NICE Foundation)
for coordinating delivery of the intervention and human resource management; Raja Ram
Mohan Reddy (Naandi Foundation) for management of field research staff; Mark Fisher (Effec-
tive Intervention) for database design and support; Jose´ de Sousa Ramos (J Ramos Consultoria)
for help with statistical programming; and Nadine Seward for support with updating references.
Author Contributions
Conceptualization: PB DE CF CJ VM RM PR.
Data curation: CF GP.
Formal analysis: PB CF VM GP.
Funding acquisition: PB DE CF.
Investigation: AE DE CF CJ RL VM RM PR.
Methodology: PB AE DE CF CJ RL VM RM PR.
Project administration: PB AE DE CF CJ RL VM RM.
Resources: PB.
Software: CF VM GP.
Supervision: PB DE CF CJ.
Visualization: CF.
Writing – original draft: PB AE DE CF CJ RL VM RM GP PR.
Writing – review & editing: PB AE DE CF CJ RL VM RM GP PR.
References
1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of
child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379
(9832):2151–61. https://doi.org/10.1016/S0140-6736(12)60560-1 PMID: 22579125
2. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;
361:2226–34. https://doi.org/10.1016/S0140-6736(03)13779-8 PMID: 12842379
3. World Health Organization. Newborns: reducing mortality. Available from: http://www.who.int/
mediacentre/factsheets/fs333/en/index.html. Accessed 2017 Oct 25.
4. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, et al. Age-specific
and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of
Disease Study 2010. Lancet. 2012; 380(9859):2071–94. https://doi.org/10.1016/S0140-6736(12)
61719-X PMID: 23245603
5. Bhutta ZA, Chopra M, Axelson H, Berman P, Boerma T, Bryce J, et al. Countdown to 2015 decade
report (2000–10): taking stock of maternal, newborn, and child survival. Lancet. 2010; 375
(9730):2032–44. https://doi.org/10.1016/S0140-6736(10)60678-2 PMID: 20569843
6. Bhutta ZA, Darmstadt GL, Hasan BS, Haws RA. Community-based interventions for improving perinatal
and neonatal health outcomes in developing countries: a review of the evidence. Pediatrics. 2005; 115
(2 Suppl):519–617.
7. Ministry of Health and Family Welfare. Andhra Pradesh: National Family Health Survey (NFHS-3)—
2005–06. Available from: http://rchiips.org/NFHS/NFHS-3%20Data/ap_state_report_printed_version_
for_website.pdf. Accessed 2017 May 23.
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 25 / 28
8. Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths:
when? Where? Why? Lancet. 2005; 365(9462):891–900. https://doi.org/10.1016/S0140-6736(05)
71048-5 PMID: 15752534
9. Million Death Study Collaborators, Bassani DG, Kumar R, Awasthi S, Morris SK, Paul VK, et al. Causes
of neonatal and child mortality in India: a nationally representative mortality survey. Lancet. 2010; 376
(9755):1853–60. https://doi.org/10.1016/S0140-6736(10)61461-4 PMID: 21075444
10. Chaudhury N, Hammer J, Kremer M, Muralidharan K, Rogers FH. Missing in action: teacher and health
worker absence in developing countries. J Econ Perspect. 2006; 20(1):91–116. PMID: 17162836
11. Bang AT, Bang RA, Baitule SB Reddy MH, Deshmukh MD. Effect of home-based neonatal care and
management of sepsis on neonatal mortality: field trial in rural India. Lancet. 1999; 354(9194):1955–61.
https://doi.org/10.1016/S0140-6736(99)03046-9 PMID: 10622298
12. Kumar V, Mohanty S, Kumar A, Misra RP, Santosham M, Awasthi S, et al. Effect of community-based
behaviour change management on neonatal mortality in Shivgarh, Uttar Pradesh, India: a cluster-ran-
domised controlled trial. Lancet. 2008; 372(9644):1151–62. https://doi.org/10.1016/S0140-6736(08)
61483-X PMID: 18926277
13. Tripathy P, Nair N, Barnett S, Mahapatra R, Borghi J, Rath S, et al. Effect of a participatory intervention
with women’s groups on birth outcomes and maternal depression in Jharkhand and Orissa, India: a
cluster-randomised controlled trial. Lancet. 2010; 375(9721):1182–92. https://doi.org/10.1016/S0140-
6736(09)62042-0 PMID: 20207411
14. Bhandari N, Mazumder S, Taneja S, Sommerfelt H, Strand TA. Effect of implementation of Integrated
Management of Neonatal and Childhood Illness (IMNCI) programme on neonatal and infant mortality:
cluster randomised controlled trial. BMJ. 2012; 344:e1634. https://doi.org/10.1136/bmj.e1634 PMID:
22438367
15. Loevinsohn B, Harding A. Buying results? Contracting for health service delivery in developing coun-
tries. Lancet. 2005; 366(9486):676–81. https://doi.org/10.1016/S0140-6736(05)67140-1 PMID:
16112305
16. Lagarde M, Palmer N. The impact of contracting out on health outcomes and use of health services in
low and middle income countries. Cochrane Database Syst Rev. 2009; 7(4):CD008133.
17. Bellows NM, Bellows B, Warren C. Systematic review: the use of vouchers for reproductive health ser-
vices in developing countries: systematic review. Trop Med Int Health. 2011; 16(1):84–96. https://doi.
org/10.1111/j.1365-3156.2010.02667.x PMID: 21044235
18. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L. Evidence-based, cost-effective
interventions: how many newborn babies can we save? Lancet. 2005; 365(9463):977–88. https://doi.
org/10.1016/S0140-6736(05)71088-6 PMID: 15767001
19. Haws RA, Thomas AL, Bhutta ZA, Darmstadt GL. Impact of packaged interventions on neonatal health:
a review of the evidence. Health Policy Plan. 2007; 22(4):193–215. https://doi.org/10.1093/heapol/
czm009 PMID: 17526641
20. Rani TU, Jampana VR, Machiraju VM (2014) Newborn survival in India—challenges and priorities for
Andhra Pradesh. J Neonatal Biol 3:150.
21. International Institute for Population Sciences. District Level Household and Facility Survey: 2007–08:
India. Andhra Pradesh: Mumbai: International Institute for Population Sciences; 2010. Available from:
http://rchiips.org/pdf/INDIA_REPORT_DLHS-3.pdf. Accessed 2017 Jun 13.
22. National Rural Health Mission. Five years of NRHM. New Delhi: Ministry of Health and Family Welfare;
2009.
23. Indian Office of the Registrar General. Sample Registration System statistical report 2011. New Delhi:
Indian Office of the Registrar General; 2013. Available from: http://www.censusindia.gov.in/vital_
statistics/SRS_Report/1Contents%202011.pdf. Accessed 2017 Jun 13.
24. Ministry of Rural Development. National Rural Employment Guarantee Act 2005 (NREGA): report of
the second year—April 2006–March 2007. New Delhi: Ministry of Rural Development; 2007. Available
from: http://nrega.nic.in/NREGArpt_eng.pdf. Accessed 2017 Jun 9.
25. Mahabubnagar district. District statistics: Mahabubnagar district profile/statistics. Available from: http://
mahabubnagar.nic.in/Resources/DistStat.doc. Accessed 2012 Oct 29.
26. Sahu D, Nair S, Singh L, Gulati BK, Pandey A. Levels, trends & predictors of infant & child mortality
among Scheduled Tribes in rural India. Indian J Med Res. 2015; 141:709–19. https://doi.org/10.4103/
0971-5916.159593 PMID: 26139791
27. Census 2011. Nagarkurnool population census 2011. Available from: http://www.census2011.co.in/
data/town/575744-nagarkurnool-andhra-pradesh.html/. Accessed 2017 Jun 13.
28. International Institute for Population Sciences, ORC Macro. National Family Health Survey (NFHS-2)
1998–99: India. Mumbai: International Institute for Population Sciences; 2000.
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 26 / 28
29. Boone P, Mann V, Eble A, Mendiratta T, Mukherjee R, Figueiredo R, et al. Community health and medi-
cal provision: impact on neonates (the CHAMPION trial). BMC Pediatr. 2007; 7:26. https://doi.org/10.
1186/1471-2431-7-26 PMID: 17625023
30. Prakassama M. Maternal mortality reduction programme in Andhra Pradesh. J Health Popul Nutr.
2009; 27:220–34. PMID: 19489417
31. Lakshminarayana R, Eble A, Bhakta P, Frost C, Boon P, Elbourne D, et al. The Support to Rural India’s
Public Education System (STRIPES) trial: a cluster randomised controlled trial of supplementary teach-
ing, learning material and material support. PLoS ONE. 2013; 8(7):e65775. https://doi.org/10.1371/
journal.pone.0065775 PMID: 23874383
32. Baiden F, Bawah A, Biai S, Binka F, Boerma T, Byass P, et al. Setting international standards for verbal
autopsy. Bull World Health Organ. 2007; 85(8):570–1. https://doi.org/10.2471/BLT.07.043745 PMID:
17768508
33. Winbo IG, Serenius FH, Dahlquist GG, Kallenc BA. NICE, a new cause of death classification for still-
births and neonatal and Intrauterine deaths. Int J Epidemiol. 1998; 27(3):499–504. PMID: 9698143
34. Manandhar DS, Osrin D, Shrestha N, Mesko J, Morrison K, Tumbahangphe K, et al. Effect of a partici-
patory intervention with women’s groups on birth outcomes in Nepal: cluster-randomised controlled
trial. Lancet. 2004; 364(9438):970–9. https://doi.org/10.1016/S0140-6736(04)17021-9 PMID:
15364188
35. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73
(1):13–22.
36. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios! Evid Based Med. 1996; 1(6):164–6.
37. Lee Y, Nelder JA. Conditional and marginal models: another view. Stat Sci. 2004; 19(2):219–38.
38. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of random-
ized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Can-
cer. 1976; 34(6):585–612. PMID: 795448
39. Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coeffi-
cient for binary responses in cancer prevention cluster randomized trials. Contemp Clin Trials. 2012; 33
(5):869–80. https://doi.org/10.1016/j.cct.2012.05.004 PMID: 22627076
40. Oestergaard MZ, Inoue M, Yoshida S, Mahanani WR, Gore FM, Cousens S, et al. Neonatal mortality
levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections,
and priorities. PLoS Med. 2011; 8(8):e1001080. https://doi.org/10.1371/journal.pmed.1001080 PMID:
21918640
41. Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, et al. The Ottawa statement on
the ethical design and conduct of cluster randomized trials. PLoS Med. 2012; 9(11):e1001346. https://
doi.org/10.1371/journal.pmed.1001346 PMID: 23185138
42. Ramji S, Modi M, Gupta N. 50 years of neonatology in India: progress and future. Indian Pediatr. 2013;
50(1):104–6. PMID: 23396782
43. Lim SS, Dandona L, Hoisington JA, James SL, Hogan MC, Gakidou E. India’s Janani Suraksha Yojana,
a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lan-
cet. 2010; 375(9730):2009–23. https://doi.org/10.1016/S0140-6736(10)60744-1 PMID: 20569841
44. Balarajan Y, Selvaraj S, Subramanian SV. Health care and equity in India. Lancet. 2011; 377
(9764):505–15. https://doi.org/10.1016/S0140-6736(10)61894-6 PMID: 21227492
45. Kumar S, Dansereau EA, Murray CJL. Does distance matter for institutional delivery in rural India? Appl
Econ. 2014; 46(33):4091–103.
46. Rammohan A, Iqbal K, Awofeso N. Reducing neonatal mortality in India: critical role of access to emer-
gency obstetric care. PLoS ONE. 2013; 8(3):e57244. https://doi.org/10.1371/journal.pone.0057244
PMID: 23544038
47. Randive B, San Sebastian M, De Costa A, Lindholm L. Inequalities in institutional delivery uptake and
maternal mortality reduction in the context of cash incentive program, Janani Suraksha Yojana: results
from nine states in India. Soc Sci Med. 2014; 123:1–6. https://doi.org/10.1016/j.socscimed.2014.10.042
PMID: 25462599
48. Raman AV, Bjo¨rkman JW. Public/private partnership in the provision of health care services to the poor
in India. In: Dinello N, Shaoguang W, editors. China, India and beyond—development drivers and limita-
tions. Cheltonham: Edward Elger Publishing; 2009. pp. 143–172.
49. Bhat R, Maheshwari S, Saha S. Contracting-out of reproductive and child health (RCH) services
through mother NGO scheme in India: experiences and implications. Vastrapur: Indian Institute of
Management Ahmedabad; 2007.
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 27 / 28
50. Lassi ZS, Bhutta ZA. Community-based intervention packages for reducing maternal and neonatal mor-
bidity and mortality and improving neonatal outcomes. Cochrane Database Syst Rev. 2015: 3:
CD007754.
51. Bhutta ZA, Das JK, Bahl R, Lawn JE, Salam BA, Paul VK, et al. Can available interventions end pre-
ventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet. 2014; 384
(9940):347–70. https://doi.org/10.1016/S0140-6736(14)60792-3 PMID: 24853604
52. Prost A, Colbourn T, Seward N, Azad K, Coomarasamy A, Copas A, et al. Women’s groups practising
participatory learning and action to improve maternal and newborn health in low-resource settings: a
systematic review and meta-analysis. Lancet. 2013; 381(9879):1736–46. https://doi.org/10.1016/
S0140-6736(13)60685-6 PMID: 23683640
53. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;
16:1–31. PMID: 10167341
CHAMPION cluster randomised trial, Telangana, India
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002324 July 5, 2017 28 / 28
